Russia, Dr Reddy’s tie up for Sputnik V trial

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of Sputnik V vaccine in India with deliveries for general use potentially beginning late this year.